Retrotransposon: an insight into neurological disorders from perspectives of neurodevelopment and aging
Wenchuan Zhang,
No information about this author
Chongtian Huang,
No information about this author
Haiyang Yao
No information about this author
et al.
Translational Neurodegeneration,
Journal Year:
2025,
Volume and Issue:
14(1)
Published: March 25, 2025
Abstract
Neurological
disorders
present
considerable
challenges
in
diagnosis
and
treatment
due
to
their
complex
diverse
etiology.
Retrotransposons
are
a
type
of
mobile
genetic
element
that
increasingly
revealed
play
role
these
diseases.
This
review
provides
detailed
overview
recent
developments
the
study
retrotransposons
neurodevelopment,
neuroaging,
neurological
Retrotransposons,
including
long
interspersed
nuclear
elements-1,
Alu,
SINE-VNTR-Alu,
endogenous
retrovirus,
important
regulatory
roles
development
aging
nervous
system.
They
have
also
been
implicated
pathological
processes
several
diseases,
Alzheimer's
disease,
X-linked
dystonia-parkinsonism,
amyotrophic
lateral
sclerosis,
autism
spectrum
disorder,
schizophrenia.
provide
new
perspective
for
understanding
molecular
mechanisms
underlying
diseases
insights
into
diagnostic
therapeutic
strategies
Language: Английский
Review: Utility of mass spectrometry in rare disease research and diagnosis
npj Genomic Medicine,
Journal Year:
2025,
Volume and Issue:
10(1)
Published: March 31, 2025
Individuals
affected
by
a
rare
disease
often
experience
long
and
arduous
diagnostic
odyssey.
Delivery
of
genetic
answers
in
timely
manner
is
critical
to
individuals
their
families.
Multi-omics,
term
which
usually
encompasses
genomics,
transcriptomics,
proteomics,
metabolomics
lipidomics,
has
gained
increasing
popularity
research
diagnosis
over
the
past
decade.
Mass
spectrometry
(MS)
technique
allowing
study
proteins,
metabolites
lipids
fragments
at
scale,
enabling
researchers
effectively
determine
presence
abundance
thousands
molecules
single
test,
accurately
quantify
specific
levels,
identify
potential
therapeutic
biomarkers,
detect
differentially
expressed
proteins
patients
with
diseases,
monitor
progression
treatment
response.
In
this
review,
we
focus
on
mass
(MS)-based
omics
survey
literature
describing
utility
different
MS-based
how
they
have
transformed
diagnosis.
Language: Английский
SAK3 confers neuroprotection in the neurodegeneration model of X-linked Dystonia-Parkinsonism
Research Square (Research Square),
Journal Year:
2024,
Volume and Issue:
unknown
Published: April 25, 2024
Abstract
Background
X-linked
Dystonia-Parkinsonism(XDP)
is
an
adult-onset
neurodegenerative
disorder
that
results
in
the
loss
of
striatal
medium
spiny
neurons
(MSNs).
XDP
associated
with
disease-specific
mutations
and
around
TAF1
gene.
This
study
highlights
utility
directly
reprogrammed
MSNs
from
fibroblasts
affected
individuals
as
a
platform
captures
cellular
epigenetic
phenotypes
XDP-related
neurodegeneration.
In
addition,
current
demonstrates
neuroprotective
effect
SAK3
currently
tested
other
diseases.
Methods
three
independent
patients
well
age-
sex-matched
control
were
used
to
generate
by
direct
neuronal
reprogramming
using
miRNA-9/9*-124
thetranscription
factors
CTIP2,
DLX1-P2A-
DLX2,
MYT1L.
Neuronal
death,
DNA
damage,
mitochondrial
health
assays
carried
out
assess
state
(XDP-MSNs).
RNA
sequencing
ATAC
performed
infer
changes
transcriptomic
chromatin
landscapesof
XDP-MSNs
compared
those
(Ctrl-MSNs).
Results
Our
show
patient
can
be
successfully
into
display
several
degenerative
phenotypes,
including
dysfunction,
Ctrl-MSNs
individuals’
fibroblasts.
showed
increased
vulnerability
TNFα
-toxicity
Ctrl-MSNs.
To
dissect
altered
XDP-MSNs,
we
conducted
accessibility
analyses
RNA-
ATAC-seq.
indicate
pathways
related
function,
calcium
signaling,
genes
diseases
are
commonly
multiple
patients.
Interestingly,
found
SAK3,
T-type
channel
activator,
may
have
therapeutic
values
disorders,
protected
death.
Notably,
SAK3-mediated
alleviation
neurodegeneration
was
accompanied
gene
expression
toward
Language: Английский
Deciphering the Pathophysiological Mechanisms Underpinning Myoclonus Dystonia Using Pluripotent Stem Cell-Derived Cellular Models
Cells,
Journal Year:
2024,
Volume and Issue:
13(18), P. 1520 - 1520
Published: Sept. 10, 2024
Dystonia
is
a
movement
disorder
with
an
estimated
prevalence
of
1.2%
and
characterised
by
involuntary
muscle
contractions
leading
to
abnormal
postures
pain.
Only
symptomatic
treatments
are
available
no
disease-modifying
or
curative
therapy,
in
large
part
due
the
limited
understanding
underlying
pathophysiology.
However,
inherited
monogenic
forms
dystonia
provide
opportunity
for
development
disease
models
examine
these
mechanisms.
Myoclonus
Dystonia,
caused
Language: Английский
G-quadruplex DNA and RNA in cellular senescence
Frontiers in Aging,
Journal Year:
2024,
Volume and Issue:
5
Published: Oct. 9, 2024
Normal
cells
divide,
are
damaged,
and
repaired
across
their
lifetime.
As
age,
they
enter
cellular
senescence,
characterized
by
a
permanent
state
of
cell-cycle
arrest
triggered
various
stressors.
The
molecular
mechanisms
that
regulate
senescent
phenotypes
have
been
actively
investigated
over
the
last
several
decades;
however,
one
area
has
neglected
is
how
G-quadruplex
(G4)
DNA
RNA
(G4-DNA
G4-RNA)
mediate
senescence.
These
non-canonical
four-stranded
structures
most
normative
RNA-dependent
processes,
such
as
transcription,
replication,
translation,
well
pathogenic
mechanisms,
including
genomic
instability
abnormal
stress
granule
function.
This
review
also
highlights
contribution
G4s
to
sex
differences
in
age-associated
diseases
emphasizes
potential
translational
approaches
target
senescence
anti-aging
through
G4
manipulation.
Language: Английский